For example, in cultured human luteinized GCs from normal ovaries, increasing doses of testosterone at concentrations observed in PCOS follicles significantly inhibited both CYP19 mRNA and protein, an effect that was rescued by the androgen receptor antagonist flutamide (Yang et al., 2015). This evidence concerns the gene CYP19A1 and polycystic ovary syndrome.